Mendra

Mendra is a biopharmaceutical company aimed at leveraging artificial intelligence (AI) to advance promising therapies for rare diseases, with the goal of modernizing the development and commercialization of treatments for such conditions. The company plans to use AI to accelerate patient identification, clinical trial enrollment, and entry into global markets.